Clinical trial
Ferumoxytol Enhanced Hippocampal Vascular Imaging in Epilepsy
NCT06483061 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ferumoxytol Enhanced Hippocampal Vascular Imaging in Epilepsy
- Lead sponsor
- University of Alberta
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- May 1, 2025
- Completion date
- September 1, 2029
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.